| Q89360925 | A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes |
| Q91672989 | Antidiabetic medication use during pregnancy: an international utilization study |
| Q89625695 | Cognitive function in metformin exposed children, born to mothers with PCOS - follow-up of an RCT |
| Q57786921 | Developmental Programming of Obesity and Diabetes in Mouse, Monkey, and Man in 2018: Where Are We Headed? |
| Q90210722 | Drugs to Control Diabetes During Pregnancy |
| Q92982363 | Early life programming in mice by maternal overnutrition: mechanistic insights and interventional approaches |
| Q92182130 | Gestational Diabetes Mellitus |
| Q91809506 | Gestational diabetes mellitus |
| Q89704874 | Growth and other health outcomes of 2-year-old singletons born after IVM versus controlled ovarian stimulation in mothers with polycystic ovary syndrome |
| Q91610468 | Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy |
| Q92861227 | Improving pregnancy outcomes in women with diabetes mellitus: modern management |
| Q91295983 | Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5-10 year follow-up of the PregMet randomised controlled trial |
| Q63358849 | Long-Term Effects of Oral Antidiabetic Drugs During Pregnancy on Offspring: A Systematic Review and Meta-analysis of Follow-up Studies of RCTs |
| Q92005412 | Management of Preexisting Diabetes in Pregnancy: A Review |
| Q64979302 | Maternal Metformin Treatment Improves Developmental and Metabolic Traits of IUGR Fetuses. |
| Q97066974 | Metformin during Pregnancy: Effects on Offspring Development and Metabolic Function |
| Q58700210 | Metformin from mother to unborn child - Are there unwarranted effects? |
| Q59812969 | Metformin in Reproductive Biology |
| Q91013918 | Metformin in pregnancy - safe or sorry? |
| Q91295999 | Metformin use in polycystic ovary syndrome pregnancy impacts on offspring obesity |
| Q92451216 | Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis |
| Q88077336 | PCOS: Metformin risk for offspring |
| Q65954080 | Polycystic Ovary Syndrome: Impact of Lipotoxicity on Metabolic and Reproductive Health |
| Q93038010 | Prenatal metformin exposure or organic cation transporter 3 knock-out curbs social interaction preference in male mice |
| Q64084589 | Recent advances in the understanding and management of polycystic ovary syndrome |
| Q57476622 | Screening and Management of Gestational Diabetes Mellitus after Bariatric Surgery |
| Q63257296 | Sex and gender differences in developmental programming of metabolism |
| Q91812986 | Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial |